Partner David Bannard was quoted in a Las Vegas Sun article, “Marijuana Advertisements Might Be Banned from Las Vegas Airport,” covering why Las Vegas’ McCarran International Airport wants to ban taxis bearing marijuana ads from transporting passengers to and from the airport.
“[McCarren doesn’t] want to create an atmosphere that suggests they’re pushing people toward [marijuana]. Airports may (already) limit hard alcohol; they may limit political advertisements. This is just an extension of that,” Bannard explained.
He added that public perception of marijuana “continues to be an issue that people are uncomfortable about. People (in the aviation industry) talk about damage that’s not physical but reputational. Airports really work hard to maintain their good image. Airports in this country are so safe and so well run. Even when (marijuana) is legal to possess, given a choice, it makes more sense to preserve that perception.”
“[McCarren doesn’t] want to create an atmosphere that suggests they’re pushing people toward [marijuana]. Airports may (already) limit hard alcohol; they may limit political advertisements. This is just an extension of that,” Bannard explained.
He added that public perception of marijuana “continues to be an issue that people are uncomfortable about. People (in the aviation industry) talk about damage that’s not physical but reputational. Airports really work hard to maintain their good image. Airports in this country are so safe and so well run. Even when (marijuana) is legal to possess, given a choice, it makes more sense to preserve that perception.”
Related News
13 February 2025
In the News
Gregory Husisian on USMCA Viability – 'The question is in what form?'
Foley & Lardner LLP partner Gregory Husisian assessed the viability of the U.S. – Mexico – Canada Agreement (USMCA) in the IndustryWeek article, “As Tariffs Concerns Grow, Where Is the USMCA?“
13 February 2025
In the News
Nikhil Pradhan on FDA Draft AI Drug Guidance – 'The industry is very much evolving'
Foley & Lardner LLP senior counsel Nikhil Pradhan shared insight on recent draft guidance from the U.S. Food and Drug Administration's in the MedCentral article, "FDA Draft Guidance Addresses Drug Submissions that Use AI Data."
12 February 2025
In the News